1. Home
  2. NNNN vs ECVT Comparison

NNNN vs ECVT Comparison

Compare NNNN & ECVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • ECVT
  • Stock Information
  • Founded
  • NNNN 2021
  • ECVT 1935
  • Country
  • NNNN Germany
  • ECVT United States
  • Employees
  • NNNN N/A
  • ECVT N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • ECVT Major Chemicals
  • Sector
  • NNNN Health Care
  • ECVT Industrials
  • Exchange
  • NNNN Nasdaq
  • ECVT Nasdaq
  • Market Cap
  • NNNN 267.7M
  • ECVT 791.1M
  • IPO Year
  • NNNN 2025
  • ECVT 2017
  • Fundamental
  • Price
  • NNNN $6.63
  • ECVT $7.05
  • Analyst Decision
  • NNNN
  • ECVT Strong Buy
  • Analyst Count
  • NNNN 0
  • ECVT 4
  • Target Price
  • NNNN N/A
  • ECVT $10.00
  • AVG Volume (30 Days)
  • NNNN 32.8K
  • ECVT 1.1M
  • Earning Date
  • NNNN 01-01-0001
  • ECVT 05-01-2025
  • Dividend Yield
  • NNNN N/A
  • ECVT N/A
  • EPS Growth
  • NNNN N/A
  • ECVT N/A
  • EPS
  • NNNN 0.06
  • ECVT N/A
  • Revenue
  • NNNN $8,185,146.00
  • ECVT $706,153,000.00
  • Revenue This Year
  • NNNN N/A
  • ECVT $12.44
  • Revenue Next Year
  • NNNN N/A
  • ECVT $5.15
  • P/E Ratio
  • NNNN $116.38
  • ECVT N/A
  • Revenue Growth
  • NNNN 21.95
  • ECVT 2.23
  • 52 Week Low
  • NNNN $5.18
  • ECVT $5.24
  • 52 Week High
  • NNNN $7.82
  • ECVT $10.16
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • ECVT 70.32
  • Support Level
  • NNNN N/A
  • ECVT $5.68
  • Resistance Level
  • NNNN N/A
  • ECVT $5.95
  • Average True Range (ATR)
  • NNNN 0.00
  • ECVT 0.28
  • MACD
  • NNNN 0.00
  • ECVT 0.17
  • Stochastic Oscillator
  • NNNN 0.00
  • ECVT 89.58

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About ECVT Ecovyst Inc.

Ecovyst Inc is an integrated and provider of materials, specialty catalysts and services. Its products contribute to lower emissions and cleaner air, higher fuel efficiency and cleaner fuels, and key enablers to advance transition to clean energy. The company has two reporting segments: (1) Ecoservices and (2) Advanced Materials & Catalysts. Ecoservices provides sulfuric acid recycling to the North American refining industry for the production of alkylate and provides on-purpose virgin sulfuric acid for water treatment, mining, and industrial applications. Maximum revenue is generated from Ecoservices segment.

Share on Social Networks: